glp-1 and pregnancy reddit Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, The Obesity Society GLP-1 Receptor Agonist Use in
Description
The primary outcome was all-cause death, with secondary outcomes including major adverse cardiovascular events (MACE), myocardial infarction, stroke, hospitalization, and coronary revascularization
Weight loss occurs in a dose-dependent way and exhibits a biphasic pattern: an initial quick phase induced by decreased calorie intake, followed by a slower phase indicative of metabolic tolerance and enduring behavioural modifications
Most GLP-1 medications correlated with a lower likelihood of anxiety and depression diagnoses
Time-to-event analyses showed a lower risk of hospitalization and better persistence on advanced Crohns therapies among patients receiving GLP-1 treatment (HR 0.74)
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials
Regulatory guidance and enforcement priorities can evolve
